Certain Neuroleptics Reduce Bone Mineralization in Schizophrenic Patients
- 1 January 1987
- journal article
- research article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 18 (4) , 185-188
- https://doi.org/10.1159/000118415
Abstract
A significant increase of urinary Ca and hydroxyproline levels and a decrease of urinary alkaline phosphatase activity were found in 12 schizophrenic patients receiving certain neuroleptic drugs. In these patients, the levels of active metabolites of vitamin D3 were decreased, while the levels of midmolecule parathyroid hormone were within the normal range, except for 2 cases. These results suggest that certain neuroleptics induce the increased urinary Ca excretion through suppression of active vitamin D3 formation and that chronic treatment with certain neuroleptics may induce abnormal bone mineralization.Keywords
This publication has 6 references indexed in Scilit:
- Chlorpromazine alters bone metabolism of ratsin vivoCalcified Tissue International, 1988
- Inhibitory effect of phenothiazine derivatives on bone in vivo and osteoblastic cells in vitroBiochemical Pharmacology, 1985
- Induction of rat hepatic and intestinal alkaline phosphatase activity produced by bile from bile duct-ligated animalsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1984
- Calcium Metabolism in Schizophrenic Patients on Long-Term Neuroleptic TherapyNeuropsychobiology, 1980
- Effect of Chlorpromazine on Skeletogenesis:The Result of Maternal Administration of the Drug in Experimental RatsActa Orthopaedica, 1979
- Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue CultureScience, 1965